References
- Skeggs L. T., Khan J. R., Lentz K. E., Shumway N. P. The preparation, purification, and amino acid sequence of a polypeptide renin substrate. J Exp Med. 1957; 106: 439–453
- Skeggs L. T., Lentz K. E., Kahn J. R., Shumway N. P. The synthesis of a tetradecapeptide renin substrate. J. Exp Med. 1958; 108: 283–296
- Lentz K. E., Skeggs L. T., Woods K. R., Kahn J. R., Shumway N. P. The amino acid composition of hypertensin II and its biochemical relationship to hypertensin. I. J Exp Med. 1956; 104: 183–191
- Campbell D. J. Metabolism of proenin, renin, angiotensinogen, and the angiotensis by tissues. The Renin-Angiotensin System, J. I.S. Robertson, M. G. Nicholls. Gower Medical Publishing, London 1993; 23.1–23.23
- Campbell D. J., Lawrence A. C., Towrie A., Kladis A., Valentijn A. J. Differential regulation of angiotensin peptide levels in plasma and kidney of the rat. Hypertension 1991; 18: 763–773
- Campbell D. J., Kladis A., Duncan A. M. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension 1994; 23: 439–449
- Juillerat L., Nussberger J., Ménard J., Mooser V., Christen Y., Waeber B., Graf P., Brunner H. R. Determinants of angiotensin II generation during converting enzyme inhibition. Hypertension 1990; 16: 564–572
- Clauser E., Bouhnik J., Gonzalez M. F., Corvol P., Menard J. Influence of converting-enzyme inhibition on rat des-angiotensin I-angiotensinogen. Am J Physiol. 1984; 246: E129–E133
- Lawrence A. C., Evin G., Kladis A., Campbell D. J. An alternative strategy for the radioimmunoassay of angiotensin peptides using amino-terminal-directed antisera: measurement of eight angiotensin peptides in human plasma. J Hypertens. 1990; 8: 715–724
- Thatcher R. L., Butty J. S., Whitworth J. A., Hunt V. D.U., Shaw P. F., Skinner S. L., Horowitz J. D. Potential functions of plasma prorenin; regional activation and tissue extraction. Clin Exp Hypertens [A]. 1987; 9: 1415–1434
- Johansen K. B., Marstein S., Aas P. Automated method for the determination of angiotensin-converting enzyme in serum. Scand J Clin Lab Invest. 1987; 47: 411–414
- Mendelsohn F. A.O., Lloyd C. J., Kachel C., Funder J. W. Induction by glucocorticoids of angiotensin converting enzyme production from bovine endothelial cells in culture and rat lung in vivo. J Clin Invest. 1982; 70: 684–692
- Campbell D. J., Kladis A., Valentijn A. J. Effects of losartan on angiotensin and bradykinin peptides, and angiotensin converting enzyme. J Cardiovasc Pharmacol. 1995; 26: 233–240
- Clauser E., Bouhnik J., Jaramillo H. N., Auzan C., Corvol P., Menard J. Angiotensinogen production and consumption in the adrenalectomized rat. Endocrinology 1985; 116: 274–280
- Campbell D. J. Angiotensin converting enzyme (ACE) inhibitors and kinin metabolism: Evidence that ACE inhibitors may inhibit a kininase other than ACE. Clin Exp Pharmacol Physiol. 1995; 22: 903–911
- Ménard J., Corvol P., Foliot A., Raynaud J. P. Effects of estrogens on renin substrate and uterine weights in rats. Endocrinology 1973; 93: 747–751
- Reid I A., Morris B. J., Ganong W. F. The renin-angiotensin system. Ann Rev Physiol. 1978; 40: 377–410
- Campbell D. J., Rong P., Kladis A., Rees B., Skinner S. L. Angiotensin. and bradykinin peptides in the TGR(mRen-2)27 rat. Hypertension 1995; 25: 1014–1020